Prescient Healthcare Buys Pharma MR Firm Strategic North

In London, biopharma product strategy consultancy Prescient Healthcare Group has acquired Strategic North, which partners with pharma companies to help them understand how their customers make decisions. Terms of the deal were not disclosed.

Strategic North is a healthcare market research and strategy consultancy, which applies a combination of an understanding of customer behaviour and decision making with strategic thinking, to help clients drive brand growth. The firm works with global marketing, new product planning, and insights functions to help develop brand value propositions, positioning and messaging.

As part of the deal, Strategic North's team will become party to a more than 460-person global organisation, based in nine offices around the world and six countries. Strategic North will be fully incorporated into Prescient, with strengths combined from the respective teams.

Jamie Denison-Pender (pictured), Prescient CEO, comments: 'Strategic North's strengths in commercial strategy, brand strategy and stakeholder insights will add depth to Prescient's existing client partnerships and help enhance the value we deliver to Medical, Real-World Evidence, Commercialization and Insights teams. This integration supports cross-functional teams across the life cycle by helping unlock the full potential of assets from molecule through to brand and ensuring that the voices of the payer, prescriber and patient are central to business decision making.'

Web sites: www.prescienthg.com and www.strategicnorth.com .